- Report
- February 2024
- 203 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 112 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 111 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- August 2023
- 145 Pages
Global
From €2768EUR$3,150USD£2,387GBP
- Report
- December 2023
- 146 Pages
Global
From €3128EUR$3,560USD£2,698GBP
€3910EUR$4,450USD£3,373GBP
From €2451EUR$2,789USD£2,114GBP
- Report
- September 2023
- 160 Pages
Global
From €3162EUR$3,599USD£2,728GBP
- Report
- December 2023
- 247 Pages
Global
€4389EUR$4,995USD£3,786GBP
- Report
- January 2022
- 292 Pages
Global
From €3163EUR$3,600USD£2,729GBP
- Report
- February 2019
- 93 Pages
Global
From €2856EUR$3,250USD£2,463GBP
The Multiplex Sequencing market is a subset of the genomics industry that focuses on the sequencing of multiple DNA samples simultaneously. This technology is used to analyze the genetic makeup of a sample, such as a tumor, to identify mutations or other genetic changes. Multiplex sequencing is also used to study the genetic diversity of a population, to identify genetic markers associated with disease, and to develop new diagnostic tests.
Multiplex sequencing is a rapidly growing field, with many companies offering products and services. These include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, 10x Genomics, and BGI Genomics. Show Less Read more
